(Q44281752)

1 December 2017

1 reference

title

Therapy for fungal infections (English)

1 reference

1 December 2017

G A Sarosi

1

1 reference

1 December 2017

S F Davies

series ordinal

2

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 November 1994

1 reference

1 December 2017

1 reference

1 December 2017

volume

69

1 reference

1 December 2017

issue

11

1 reference

1 December 2017

page(s)

1111-1117

1 reference

Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Chronic cavitary histoplasmosis. Failure of oral treatment with ketoconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Treatment of Chronic Pulmonary Histoplasmosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Disseminated histoplasmosis: results of long-term follow-up. A center for disease control cooperative mycoses study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Disseminated histoplasmosis in patients infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Blastomycosis in immunocompromised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Itraconazole therapy for chronic coccidioidal meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Treatment of sporotrichosis with itraconazole. NIAID Mycoses Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Invasive aspergillosis. Progress in early diagnosis and treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

The epidemiology of pseudallescheriasis complicating transplantation: Nosocomial and community-acquired infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Hepatosplenic candidiasis: successful treatment with fluconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961381-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(12)61381-0

1 reference

1 December 2017

1 reference